CFO Kevin L. Cook resigns; CEO Brian M. Culley named interim CFO effective July 8, 2022

Lineage Cell Therapeutics, Inc.

CFO Kevin L. Cook resigns effective July 8, 2022; resignation not due to any disagreement with Lineage.
CEO Brian M. Culley appointed interim CFO and principal financial officer.
Alexandra Hernandez, Sr. Director of Finance and Controller, named interim principal accounting officer.
Separation agreement provides Cook $318,975 lump sum (9 months base salary) and up to 9 months COBRA coverage.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.